Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Melanoma × Standard of Care × Clear all

Phase

Status

Completed 4 Recruiting 3 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Breast Neoplasms 5 Colorectal Neoplasms 3 Neoplasm Metastasis 2 Mouth Neoplasms 2 Lung Neoplasms 2 Vomiting 1 Stomach Neoplasms 1 Skin Carcinoma 1 Prostatic Neoplasms 1 Postoperative Complications 1 Polycystic Ovary Syndrome 1 Peripheral Arterial Disease 1 Pain 1 Opioid-Related Disorders 1 Nausea 1 Motor Activity 1 Melanoma 1 Medication Adherence 1 Malignant Solid Neoplasm 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Localized Head and Neck Carcinoma 1 Localised Prostate Cancer 1 Leukemia, Myeloid, Acute 1 Laryngeal Neoplasms 1 Ischemia 1 Hypertension 1 Heart Failure 1

Interventions

Nivolumab 2 Melphalan 2 Interleukin-2 2 trametinib 1 toripalimab 1 sulforaphane 1 secukinumab 1 relatlimab 1 pembrolizumab 1 encorafenib 1 binimetinib 1 anlotinib 1 Toll-Like Receptor 1 1 Therapeutics 1 Standard of Care 1 Specimen Handling 1 Rehabilitation 1 Ipilimumab 1 Injections 1 Immune Checkpoint Inhibitors 1 Fulvestrant 1 Doxorubicin 1 Atorvastatin 1 Afatinib 1 3-(3'-adamantan-1-yl-4'-methoxybiphenyl-4-yl)-2-propenoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06470880 2024-06-24

DyNAMIc

The Christie NHS Foundation Trust

Phase 2 Not yet recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡